Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse®…
Trial did not meet its primary endpoint related to the change in moderate to vigorous physical activity INOpulse® was safe and well-tolerated, consistent with the overall safety profile…